Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • News

Sanofi Offloads 17 Products To Neuraxpharm

By Vandana Singh
July 13, 12:38 PM
Sanofi SA (NASDAQ: SNY) has entered a deal to hand over 17 products to central nervous system (CNS) specialist Neuraxpharm for an undisclosed sum. 

SNY

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Merck Makes $290M Bet On Prostate Cancer Candidate

By Vandana Singh
July 13, 10:49 AM
Merck & Co Inc (NASDAQ:MRK) and Orion Corporation announced a global development and commercialization agreement for Orion’s ODM-208 and other drugs targeting cytochrome…

MRK

Read More
1 minute read
  • Contracts
  • Entrepreneurship
  • General
  • Large Cap
  • Long Ideas
  • Markets
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Walmart Signs Contract With Canoo To Revolutionize Home Delivery: How The Retail Giant Plans On Beating Amazon

By Dylan Wechsler
July 12, 6:04 PM
The world’s largest retailer Walmart, Inc. (NYSE: WMT) has committed to purchasing 4,500 Canoo, Inc.

AMZN

Read More
2 minute read
  • Large Cap
  • Legal
  • News
  • Top Stories

Thieves Target F-150 Raptors: Ford Facing Security Issues As Supply Chain Disruptions Leave Inventory In Storage Lots

By Robert Kuczmarski
July 12, 3:45 PM
With Ford F-150 pickups being the industry’s top-selling truck and supply chain disruptions still impacting the automotive sector, excess inventory can become prime targets for automotive thieves.

F

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

Abbott’s Deep Brain Stimulation Receives FDA’s Breakthrough Device Tag To Manage Depression

By Vandana Singh
July 12, 10:20 AM
The FDA has granted Breakthrough Device Designation to Abbott Laboratories (NYSE:ABT) deep brain stimulation (DBS) system in treatment-resistant depression (TRD), a form…

ABT

Read More
3 minute read
  • Events
  • Exclusives
  • Large Cap
  • News
  • Press Releases
  • Top Stories

These Are Amazon’s 10 Best Prime Day Deals 2022: Smart TVs, Streaming Services, Apple Watches And More

By Robert Kuczmarski
July 11, 4:22 PM
Amazon.com Inc (NYSE: AMZN) Prime Day will be kicking off Tuesday, July 12 at midnight PDT (3 a.m. EDT) and runs through July 13.

AFRM

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

With New Phase 3 Data From Its Hemophilia Study, Novo Nordisk Plots Route To FDA

By Vandana Singh
July 11, 1:24 PM
Novo Nordisk A/S (NYSE:NVO) announced the phase 3 results of the explorer7 study, assessing the efficacy and safety of prophylactic treatment…

NVO

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • News

ViaCyte Acquisition Can Accelerate Vertex’s Ongoing Type 1 Diabetes Programs

By Vandana Singh
July 11, 10:54 AM
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has agreed to acquire ViaCyte, a privately held biotechnology, for $320 million in cash. ViaCyte is focused…

VRTX

Read More
2 minute read
  • Large Cap
  • Media
  • News

Barron’s Latest Picks And Pans: Alphabet, Nike, Microsoft, Peloton And The Top-Performing CEOs Of 2022

By Michael Cohen
July 9, 5:04 PM
Benzinga reviews this weekend's top stories on Barron's, for additional information on the latest market news, Benzinga Pro offers a 24/7 news feed, live chat and charting software. 

GOOG

Read More
2 minute read
  • Large Cap
  • Long Ideas
  • News
  • Short Ideas
  • Trading Ideas

Benzinga Bulls And Bears Of The Week: Ford, Coinbase, Block, Netflix, DoorDash And This Major Chipmaker

By Michael Cohen
July 9, 12:41 PM
Benzinga has examined the prospects for many investors' favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro. 

AMZN

Posts pagination

Previous 1 … 434 435 436 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service